HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 78 filers reported holding HOMOLOGY MEDICINES INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,106 | +32.2% | 1,800 | 0.0% | 0.00% | – |
| Q2 2023 | $1,593 | -14.1% | 1,800 | 0.0% | 0.00% | – |
| Q1 2023 | $1,854 | -18.3% | 1,800 | 0.0% | 0.00% | – |
| Q4 2022 | $2,268 | -24.4% | 1,800 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 1,800 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -77.8% | 1,800 | -69.4% | 0.00% | – |
| Q1 2022 | $18,000 | +20.0% | 5,888 | +39.0% | 0.00% | – |
| Q4 2021 | $15,000 | -31.8% | 4,235 | +51.1% | 0.00% | – |
| Q3 2021 | $22,000 | +10.0% | 2,802 | +1.3% | 0.00% | – |
| Q2 2021 | $20,000 | 0.0% | 2,766 | +30.8% | 0.00% | – |
| Q1 2021 | $20,000 | +42.9% | 2,115 | +74.1% | 0.00% | – |
| Q4 2020 | $14,000 | +40.0% | 1,215 | +35.0% | 0.00% | – |
| Q3 2020 | $10,000 | 0.0% | 900 | +35.5% | 0.00% | – |
| Q2 2020 | $10,000 | +11.1% | 664 | +10.7% | 0.00% | – |
| Q1 2020 | $9,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $8,936,000 | 2.21% |
| Vida Ventures Advisors, LLC | 770,845 | $1,519,000 | 1.28% |
| OUP Management Co., LLC | 64,000 | $126,000 | 0.17% |
| Oasis Management Co Ltd. | 280,000 | $552,000 | 0.10% |
| Vivo Capital, LLC | 370,068 | $729,000 | 0.07% |
| AAF Wealth Management, LLC | 47,501 | $94,000 | 0.07% |
| TANG CAPITAL MANAGEMENT LLC | 214,898 | $423,000 | 0.06% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $11,132,462 | 0.06% |
| Bellevue Group AG | 1,622,522 | $3,196,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 128,353 | $253,000 | 0.04% |